Prognosis
Novo’s Obesity Drug Arrives in UK – at a Fraction of US Prices
- Tens of thousands of people are on waiting lists for Wegovy
- The Danish company’s treatment starts at £199 for UK patients
This article is for subscribers only.
People struggling to lose weight in the UK are finally able to get their hands on the weight-loss drug Wegovy – at a fraction of the costs facing US patients.
But most who have signed up to take the weekly self-injections will remain on the waiting list for some time, as only limited supplies have been released by Novo Nordisk in a “controlled and limited launch.”